- Home
- CTRN vs SGP Comparison
CTRN vs SGP Comparison
Compare CTRN & SGP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CTRN | SGP |
|---|---|---|
| Founded | 1946 | 2019 |
| Country | United States | United States |
| Employees | N/A | 65 |
| Industry | Clothing/Shoe/Accessory Stores | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 559.1M | 650.9M |
| IPO Year | 2005 | N/A |
Fundamental Metrics
Financial Performance| Metric | CTRN | SGP |
|---|---|---|
| Price | $72.06 | $25.09 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 5 |
| Target Price | ★ $52.00 | $45.00 |
| AVG Volume (30 Days) | ★ 113.1K | 97.2K |
| Earning Date | 06-02-2026 | 05-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 112.14 | N/A |
| EPS | ★ 0.91 | N/A |
| Revenue | ★ $819,962,000.00 | N/A |
| Revenue This Year | $8.81 | N/A |
| Revenue Next Year | $8.35 | N/A |
| P/E Ratio | $79.18 | ★ N/A |
| Revenue Growth | ★ 8.88 | N/A |
| 52 Week Low | $29.60 | $17.06 |
| 52 Week High | $73.39 | $30.56 |
Technical Indicators
Market Signals| Indicator | CTRN | SGP |
|---|---|---|
| Relative Strength Index (RSI) | 69.04 | 68.69 |
| Support Level | $42.10 | $20.95 |
| Resistance Level | N/A | $25.83 |
| Average True Range (ATR) | 2.58 | 1.34 |
| MACD | 0.43 | 0.38 |
| Stochastic Oscillator | 89.18 | 95.56 |
Price Performance
Historical ComparisonAbout CTRN Citi Trends Inc.
Citi Trends Inc is a differentiated off-price value retailer known for trendy fashions, great brands and amazing prices. It is the off-price retailer specifically focused on Black customers, delivering the styles, brands, and trends at amazing prices that resonate with its primary and secondary customers. Its product offering is Women's, Men's and Children's apparel, family footwear, accessories and products for the home, with a three-tiered mix of product. At the opening price point, the company offers value-focused basics for its budget-conscious customers.
About SGP SpyGlass Pharma Inc. Common Stock
SpyGlass Pharma Inc is a late-stage biopharmaceutical company focused on transforming the treatment paradigm for patients living with chronic eye conditions through long-acting, sustained drug delivery of approved medicines. The company is developing two programs: the BIM-IOL System, which is intended for use during cataract surgery to deliver glaucoma treatment, and the BIM-DRS, which is designed for glaucoma patients who are not undergoing cataract surgery.